Ivy extract vs NAC for COPD: Which works better?
Treatments studied
Part of Lungs & breathing clinical trials.
This study compares two treatments – a dry powder ivy extract and a common mucus-thinning medicine called NAC – to see which is safer and more effective for people with stable COPD. If you have COPD and are over 40, this trial could help find a better option to manage your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD that stays stable (not a sudden worsening)
- You are 40 years old or older
- You can perform a breathing test called spirometry
- You do not have asthma, lung cancer, or other chronic lung diseases
- You have not been taking mucolytics (medicines that thin mucus) regularly for at least a month
- You are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an inhaled medicine (GDC-6988) to see if it is safe and helps clear mucus from the lungs in people with mucus-related lung diseases like chronic bronchitis, COPD, or bronchiectasis. You may qualify if your lung function is fairly stable and you produce daily mucus.
This study tests a new injectable medicine called CM310 for people with moderate to severe COPD who have chronic bronchitis and frequent flare-ups, despite using standard inhalers. It aims to see if CM310 can reduce flare-ups and improve breathing by targeting a specific type of inflammation.
This study tests a new inhaled powder medicine (TQC3927) against an existing combination inhaler for treating COPD, a lung disease that makes breathing difficult. The goal is to see if the new medicine works as well or better and is safe for people with COPD.
This trial tests whether vitamin C supplements can improve health in people with COPD. It aims to see if the antioxidant effects of vitamin C help manage the disease and slow its progression.
This trial tests if breathing in a medication called acetylcysteine can help prevent lung infections in patients who are on a breathing machine. If you or a loved one is on a ventilator, this treatment might reduce the chance of getting ventilator-associated pneumonia.
This study compares two types of breathing support for people having a severe COPD flare-up with high carbon dioxide and acidic blood. It tests if a gentle air flow through the nose (nasal high flow) works as well as a mask (non-invasive ventilation) to help you breathe better.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.